H.E.L. Group announced the strengthening of the Company’s senior management team with Paul Orange, Ph.D. joining as Chief Marketing Officer, and Paul Sturgeon as Chief Financial Officer.
- Paul Orange Ph.D., formerly of GE Healthcare, recruited as Chief Marketing Officer
- Paul Sturgeon joins as Chief Financial Officer
Borehamwood, UK, 26 November 2019: H.E.L. Group, a global manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the strengthening of the Company’s senior management team with Paul Orange, Ph.D. joining as Chief Marketing Officer (CMO), and Paul Sturgeon as Chief Financial Officer (CFO). The news follows the appointment of CEO Louise Madden, and will further drive the Company’s strategic expansion.
With over 20 years’ experience in R&D and commercial roles at life science organizations, Paul Orange joins H.E.L. Group from GE Healthcare Life Sciences, where he led regional marketing teams around the world and drove a major e-commerce project for the multinational company. Paul has a Ph.D. in Neuroscience from the University of Sheffield, and has performed research at Manchester University, Amersham Pharmacia Biotech and NextGen Sciences. He has also worked in sales, marketing and business development roles at PerkinElmer.
Paul Sturgeon started his career as a chartered accountant with Price Waterhouse, and since then has held CFO positions at organizations ranging from pre-revenue start-ups to established, multinational private equity-backed businesses. At H.E.L. Group, Paul will focus on enhancing operational efficiency, including leading the company-wide implementation of an enterprise resource planning (ERP) system.
Louise Madden, CEO of H.E.L. Group commented: “H.E.L. Group is continuing to invest in talent with experience and expertise that supports operational excellence and drives commercial intensity. We are delighted to welcome the two Pauls to help shape both our internal and customer-facing business strategy. With an expanded senior management team, we have the right skills and a shared vision to take the Company to the next level in terms of our people, processes, infrastructure and product innovation.”
ENDS
About H.E.L. Group www.helgroup.com
H.E.L. Group develops and manufactures innovative scientific instruments and software to optimize efficiency, safety and productivity of process scale-up in chemistry and biology R&D applications.
With a team of 70, including highly skilled process and software engineers, and extensive research and manufacturing facilities in the UK, H.E.L. Group has a long history of solving complex challenges for customers. For more than 30 years the Company has worked with businesses and laboratories globally, providing proprietary automated solutions in the pharma, biotech, chemicals and petrochemicals sectors.
Following significant growth, and with annual revenues exceeding £10 million, the Company has plans to extend the reach of its products to support and enable R&D and process optimization further across the US, China and India.
